This content is for healthcare professionals only.
Please confirm you are a healthcare professional.
The International Workshop on Myeloma 2020 took place September 25–26th and highlighted recent updates in immune-based therapies, minimal residual disease (MRD), and the molecular basis of myeloma in the development of novel targets.
Some of the world’s leading clinical researchers in myeloma shared their perspectives on how to place this evolving understanding in a clinical context and thereby optimize clinical care.
The full series of presentations can be viewed on-demand below.
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest hemonc news and updates
Keep up to date with all the latest news with our monthly newsletter